Plain-English translation of NCT06536686 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying silent heart damage—injury that happens without obvious symptoms—in patients having abdominal surgery. The study will collect blood samples and genetic information to identify blood markers and genetic factors that might help predict who is at higher risk for heart problems after surgery.
Heart problems are a leading cause of death after abdominal surgery, yet doctors currently have limited ways to predict or detect this silent damage early. This research aims to find new blood tests and genetic clues that could help identify at-risk patients before harm occurs.
You will give blood samples before surgery and again on your third day in the hospital. These samples will be tested for heart injury markers and genetic information. After you leave the hospital, the research team will contact you every three months for one year to check on your health and ask about any heart-related problems you may have experienced.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Slovenia
Collaborators
University of Ljubljana
Enrollment target
~200 participants
Started
July 2024
Primary completion
July 2025
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jasna Klen, MD, PhD
University Medical Centre Ljubljana